Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
In-111-labeled EGF is selectiv...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
Bibliographic Details
Main Authors:
Reilly, R
,
Kiarash, R
,
Cameron, R
,
Porlier, N
,
Sandhu, J
,
Hill, R
,
Vallis, K
,
Hendler, A
,
Gariepy, J
Format:
Conference item
Published:
2000
Holdings
Description
Similar Items
Staff View
Similar Items
111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
by: Reilly, R, et al.
Published: (2000)
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
by: Reilly, R, et al.
Published: (2000)
Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
by: Chen, P, et al.
Published: (2002)
Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
by: Wang, J, et al.
Published: (2001)
The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
by: Chen, P, et al.
Published: (2001)